Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution

Contact Us
If you have any questions or feedback please contact us.

Holly Lindsay

Concepts (224)

Concepts are derived automatically from a person's publications.

Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Brain Neoplasms
18
2026
1331
2.810
Why?
Medulloblastoma
7
2024
215
2.060
Why?
Central Nervous System Neoplasms
7
2025
177
1.640
Why?
Cerebellar Neoplasms
6
2024
177
1.590
Why?
Ependymoma
5
2026
176
1.370
Why?
Glioma
9
2025
429
1.300
Why?
Neoplastic Syndromes, Hereditary
2
2019
47
1.160
Why?
Glioblastoma
4
2026
354
1.090
Why?
Oligodendrocyte Transcription Factor 2
1
2026
23
0.940
Why?
Lymphopenia
1
2024
62
0.810
Why?
Neoplasm Recurrence, Local
3
2026
1150
0.800
Why?
Hemophilia A
2
2014
148
0.700
Why?
Poly-ADP-Ribose Binding Proteins
1
2019
33
0.610
Why?
Neurocutaneous Syndromes
1
2019
3
0.610
Why?
DNA Polymerase II
1
2019
35
0.610
Why?
Child
33
2026
22739
0.550
Why?
Cephalosporins
1
2017
45
0.500
Why?
Xenograft Model Antitumor Assays
5
2026
936
0.500
Why?
Factor VIII
2
2014
106
0.500
Why?
Neoplasm Transplantation
2
2020
246
0.490
Why?
Germinoma
1
2016
10
0.480
Why?
Proto-Oncogene Proteins c-kit
1
2016
72
0.450
Why?
Renal Insufficiency
1
2017
172
0.440
Why?
Antineoplastic Agents
6
2025
2219
0.420
Why?
Granuloma, Pyogenic
1
2014
10
0.420
Why?
von Willebrand Disease, Type 2
1
2014
1
0.420
Why?
Coagulants
1
2014
20
0.420
Why?
Infratentorial Neoplasms
2
2026
71
0.420
Why?
Mouth Diseases
1
2014
48
0.410
Why?
Child, Preschool
16
2026
11868
0.400
Why?
DNA Repair Enzymes
1
2013
29
0.380
Why?
Prognosis
10
2026
4329
0.380
Why?
Neoplasms, Multiple Primary
1
2013
58
0.370
Why?
Adenosine Triphosphatases
1
2013
159
0.360
Why?
Neoplasms
5
2026
2913
0.350
Why?
Gene Deletion
1
2013
392
0.340
Why?
Colorectal Neoplasms
1
2019
868
0.340
Why?
Colonic Neoplasms
1
2013
258
0.320
Why?
DNA-Binding Proteins
2
2019
1482
0.320
Why?
Chemoradiotherapy
3
2026
239
0.300
Why?
Antineoplastic Combined Chemotherapy Protocols
4
2026
1969
0.290
Why?
Follow-Up Studies
8
2026
5428
0.280
Why?
Humans
40
2026
145763
0.280
Why?
Adolescent
16
2026
22573
0.270
Why?
Cancer Survivors
2
2026
338
0.270
Why?
Neoplastic Stem Cells
3
2024
409
0.260
Why?
Survival Rate
4
2026
2094
0.250
Why?
Anti-Bacterial Agents
1
2017
1925
0.240
Why?
Male
21
2026
73003
0.240
Why?
Proto-Oncogene Proteins c-mdm2
1
2026
67
0.240
Why?
Cell Line, Tumor
6
2026
3551
0.230
Why?
Adenocarcinoma
1
2013
926
0.230
Why?
Trastuzumab
1
2026
118
0.230
Why?
Hydroxamic Acids
1
2025
94
0.230
Why?
Pyrimidines
4
2025
530
0.220
Why?
Female
22
2026
79035
0.220
Why?
Granulocyte-Macrophage Colony-Stimulating Factor
1
2026
161
0.220
Why?
Mice, SCID
4
2021
369
0.220
Why?
Cisplatin
2
2024
345
0.220
Why?
Receptor, trkA
1
2025
18
0.220
Why?
Gene Fusion
1
2025
30
0.220
Why?
Proton Therapy
1
2024
15
0.210
Why?
AC133 Antigen
1
2024
20
0.210
Why?
CD57 Antigens
1
2024
18
0.210
Why?
Craniospinal Irradiation
1
2024
5
0.210
Why?
Gangliosides
1
2024
23
0.210
Why?
Hematologic Neoplasms
1
2026
168
0.210
Why?
MicroRNAs
2
2021
686
0.210
Why?
Histone Deacetylase Inhibitors
1
2025
218
0.200
Why?
Aftercare
1
2026
222
0.200
Why?
Cochlea
1
2024
73
0.200
Why?
Antimetabolites, Antineoplastic
1
2024
106
0.200
Why?
Young Adult
10
2026
14251
0.200
Why?
Infant
9
2026
10090
0.190
Why?
Methotrexate
1
2024
233
0.190
Why?
Proto-Oncogene Proteins
1
2026
625
0.190
Why?
Oncogene Proteins, Fusion
1
2025
212
0.190
Why?
Biomarkers, Tumor
4
2019
1329
0.190
Why?
Cell Survival
1
2026
1103
0.180
Why?
Neoplasm Invasiveness
1
2024
508
0.180
Why?
Symporters
1
2022
48
0.180
Why?
Cell Cycle Proteins
1
2026
630
0.180
Why?
Aurora Kinase A
2
2023
61
0.180
Why?
Craniopharyngioma
1
2023
77
0.180
Why?
Spinal Cord Neoplasms
1
2022
41
0.170
Why?
Azepines
2
2023
105
0.170
Why?
Rhabdoid Tumor
1
2023
102
0.170
Why?
Enhancer of Zeste Homolog 2 Protein
1
2021
55
0.170
Why?
Nuclear Proteins
1
2026
740
0.170
Why?
Pituitary Neoplasms
1
2023
190
0.160
Why?
Gadolinium
1
2021
84
0.160
Why?
Phenotype
3
2021
3170
0.160
Why?
Hearing Loss
1
2024
249
0.160
Why?
Product Surveillance, Postmarketing
1
2020
74
0.160
Why?
Peptides
1
2026
998
0.160
Why?
Tumor Suppressor Protein p53
2
2026
534
0.160
Why?
Hypothalamic Diseases
1
2020
17
0.160
Why?
Legislation, Drug
1
2020
73
0.160
Why?
Mice
8
2026
18355
0.160
Why?
Methylphenidate
1
2020
49
0.150
Why?
Mutation
5
2026
4090
0.150
Why?
Neurofibromin 1
1
2019
26
0.150
Why?
Survival Analysis
3
2020
1378
0.150
Why?
N-Myc Proto-Oncogene Protein
1
2019
11
0.150
Why?
Chromosomes, Human, Pair 19
1
2019
27
0.150
Why?
DNA Mismatch Repair
1
2019
53
0.150
Why?
Protein Kinase Inhibitors
3
2025
981
0.150
Why?
Germ Cells
1
2019
66
0.150
Why?
Animals
11
2026
38097
0.150
Why?
Histones
2
2022
666
0.140
Why?
Pharmaceutical Preparations
1
2020
171
0.140
Why?
Digoxin
1
2018
27
0.140
Why?
Multigene Family
1
2019
210
0.140
Why?
Germ-Line Mutation
1
2019
177
0.140
Why?
Drug Repositioning
1
2018
39
0.140
Why?
DNA Mutational Analysis
1
2019
410
0.140
Why?
Drug-Related Side Effects and Adverse Reactions
1
2020
261
0.140
Why?
Central Nervous System Stimulants
1
2020
185
0.140
Why?
Retrospective Studies
7
2025
17325
0.140
Why?
Neoplasms, Germ Cell and Embryonal
1
2019
76
0.140
Why?
Enzyme Inhibitors
1
2021
821
0.140
Why?
Systems Biology
1
2018
68
0.130
Why?
Adult
8
2026
40872
0.130
Why?
Cell Culture Techniques
1
2020
375
0.130
Why?
Neoplasm Metastasis
2
2021
688
0.130
Why?
Fever of Unknown Origin
1
2017
13
0.130
Why?
Quality Improvement
1
2026
1296
0.120
Why?
Caregivers
1
2026
1074
0.120
Why?
Genetic Testing
1
2019
483
0.120
Why?
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
2019
297
0.120
Why?
Precursor B-Cell Lymphoblastic Leukemia-Lymphoma
1
2017
89
0.120
Why?
Quality of Life
3
2023
3210
0.120
Why?
Radiation Tolerance
1
2016
103
0.120
Why?
Proto-Oncogene Proteins c-fos
1
2016
196
0.120
Why?
Heterografts
1
2016
143
0.110
Why?
Immunohistochemistry
2
2018
1723
0.110
Why?
Magnetic Resonance Imaging
3
2023
3915
0.110
Why?
RNA-Binding Proteins
1
2019
447
0.110
Why?
Treatment Outcome
6
2026
11793
0.110
Why?
Weight Loss
1
2020
859
0.100
Why?
Chromosome Aberrations
1
2014
166
0.100
Why?
Genetic Predisposition to Disease
2
2019
2399
0.100
Why?
von Willebrand Factor
1
2014
85
0.100
Why?
Pediatrics
1
2022
1125
0.100
Why?
Mismatch Repair Endonuclease PMS2
1
2013
4
0.100
Why?
Morpholines
2
2025
130
0.100
Why?
Heterozygote
1
2014
314
0.100
Why?
Sequence Analysis, DNA
1
2016
778
0.100
Why?
Combined Modality Therapy
2
2026
1270
0.080
Why?
Neoplasm Grading
2
2024
311
0.080
Why?
Alleles
1
2013
896
0.080
Why?
Risk Factors
1
2024
10917
0.070
Why?
Mice, Inbred NOD
2
2021
616
0.070
Why?
Brain
2
2021
2969
0.070
Why?
Recurrence
2
2022
1139
0.070
Why?
Cell Proliferation
3
2021
2514
0.060
Why?
Tumor Cells, Cultured
2
2020
887
0.060
Why?
Obesity
1
2020
3118
0.060
Why?
Injections, Spinal
1
2026
120
0.060
Why?
Epigenesis, Genetic
2
2022
693
0.060
Why?
Circulating Tumor DNA
1
2026
46
0.060
Why?
Sulfur Compounds
1
2025
7
0.060
Why?
Maximum Tolerated Dose
1
2025
211
0.060
Why?
Apoptosis
3
2018
2443
0.050
Why?
Disease Models, Animal
3
2021
4568
0.050
Why?
Cell Cycle
2
2019
598
0.050
Why?
Receptor, trkB
1
2025
39
0.050
Why?
Interleukin-7 Receptor alpha Subunit
1
2024
11
0.050
Why?
Mucositis
1
2024
20
0.050
Why?
Chromosomes
1
2024
106
0.050
Why?
Neutropenia
1
2024
154
0.050
Why?
Fluorouracil
1
2024
231
0.050
Why?
Infant, Newborn
1
2014
6464
0.050
Why?
Biphenyl Compounds
1
2021
67
0.040
Why?
Dissection
1
2021
57
0.040
Why?
Radiotherapy Dosage
1
2021
288
0.040
Why?
Drug Evaluation, Preclinical
1
2021
196
0.040
Why?
Serial Passage
1
2020
2
0.040
Why?
Government Regulation
1
2020
39
0.040
Why?
Pyrazoles
1
2025
517
0.040
Why?
Benzamides
1
2021
226
0.040
Why?
Drug Interactions
1
2022
405
0.040
Why?
Patient-Specific Modeling
1
2020
45
0.040
Why?
Immunotherapy, Adoptive
1
2024
342
0.040
Why?
Drug Resistance, Neoplasm
1
2025
883
0.040
Why?
United States Food and Drug Administration
1
2020
208
0.040
Why?
Thalamus
1
2021
129
0.040
Why?
Pyridones
1
2021
209
0.040
Why?
Chromosomes, Human, Pair 2
1
2019
28
0.040
Why?
Rhabdomyosarcoma
1
2019
65
0.040
Why?
Osteosarcoma
1
2019
89
0.040
Why?
Medical Oncology
1
2022
340
0.040
Why?
Oncogenes
1
2019
118
0.040
Why?
Wilms Tumor
1
2019
90
0.030
Why?
Sarcoma, Ewing
1
2019
103
0.030
Why?
DNA Copy Number Variations
1
2019
188
0.030
Why?
Radiation, Ionizing
1
2018
86
0.030
Why?
Neuroblastoma
1
2019
174
0.030
Why?
Contrast Media
1
2021
497
0.030
Why?
Enhancer Elements, Genetic
1
2019
191
0.030
Why?
Genetic Association Studies
1
2019
371
0.030
Why?
DNA Methylation
1
2022
690
0.030
Why?
Cell Transformation, Neoplastic
1
2019
337
0.030
Why?
Age Factors
1
2024
3346
0.030
Why?
Immunophenotyping
1
2018
322
0.030
Why?
Gene Regulatory Networks
1
2019
318
0.030
Why?
Blood-Brain Barrier
1
2018
160
0.030
Why?
Cytogenetic Analysis
1
2014
34
0.030
Why?
Serum Albumin, Bovine
1
2014
62
0.030
Why?
Gene Expression Profiling
1
2021
1777
0.030
Why?
Transplantation, Heterologous
1
2014
170
0.030
Why?
Clinical Trials as Topic
1
2019
1062
0.030
Why?
Genomics
1
2019
830
0.030
Why?
Flow Cytometry
1
2018
1165
0.030
Why?
Gene Expression Regulation, Neoplastic
1
2018
1450
0.020
Why?
Cattle
1
2014
946
0.020
Why?
Models, Biological
1
2019
1764
0.020
Why?
Mitochondria
1
2018
992
0.020
Why?
Aged
2
2025
26215
0.020
Why?
Gene Expression Regulation
1
2019
2601
0.020
Why?
Middle Aged
2
2025
36302
0.020
Why?
Biomarkers
1
2018
4302
0.010
Why?
Signal Transduction
1
2018
5223
0.010
Why?
United States
1
2020
16123
0.010
Why?
Lindsay's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
_
Co-Authors Expand Description
_
Similar People Expand Description
_
Same Department Expand Description

Copyright © 2026 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)